Literature DB >> 650388

[Biochemical studies on vasodilative factor in royal jelly (author's transl)].

M Shinoda, S Nakajin, T Oikawa, K Sato, A Kamogawa, Y Akiyama.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 650388     DOI： 10.1248/yakushi1947.98.2_139

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN： 0031-6903            Impact factor:   0.302


× No keyword cloud information.
  11 in total

1.  The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats.

Authors:  Sibel Silici; Oguz Ekmekcioglu; Murat Kanbur; Kemal Deniz
Journal:  World J Urol       Date:  2010-04-06       Impact factor: 4.226

2.  The efficacy of topical royal jelly on healing of diabetic foot ulcers: a double-blind placebo-controlled clinical trial.

Authors:  Mansour Siavash; Saeideh Shokri; Sepehr Haghighi; Mohammad Ali Shahtalebi; Ziba Farajzadehgan
Journal:  Int Wound J       Date:  2013-04-08       Impact factor: 3.315

3.  Royal jelly modulates oxidative stress and tissue injury in gamma irradiated male Wister Albino rats.

Authors:  Khaled Shaaban Azab; Mohamed Bashandy; Mahmoud Salem; Osama Ahmed; Zaki Tawfik; Hamed Helal
Journal:  N Am J Med Sci       Date:  2011-06

4.  The efficacy of topical Royal Jelly on diabetic foot ulcers healing: A case series.

Authors:  Mansour Siavash; Saeideh Shokri; Sepehr Haghighi; Mahbubeh Mohammadi; Mohammad Ali Shahtalebi; Ziba Farajzadehgan
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

5.  The effects of royal jelly on autoimmunity in Graves' disease.

Authors:  Cihangir Erem; Orhan Deger; Ercüment Ovali; Yasam Barlak
Journal:  Endocrine       Date:  2006-10       Impact factor: 3.925

6.  The functional property of royal jelly 10-hydroxy-2-decenoic acid as a melanogenesis inhibitor.

Authors:  Chi-Chung Peng; Hui-Tzu Sun; I-Ping Lin; Ping-Chung Kuo; Jen-Chieh Li
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

7.  Comparison of bee products based on assays of antioxidant capacities.

Authors:  Yoshimi Nakajima; Kazuhiro Tsuruma; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  BMC Complement Altern Med       Date:  2009-02-26       Impact factor: 3.659

8.  10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-22       Impact factor: 2.629

9.  Bee products prevent VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Masamitsu Shimazawa; Kazuhiro Tsuruma; Yoko Araki; Satoshi Mishima; Hideaki Hara
Journal:  BMC Complement Altern Med       Date:  2009-11-17       Impact factor: 3.659

10.  Protective effect of royal jelly on the sperm parameters and testosterone level and lipid peroxidation in adult mice treated with oxymetholone.

Authors:  Ensieh Zahmatkesh; Gholamreza Najafi; Vahid Nejati; Reza Heidari
Journal:  Avicenna J Phytomed       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.